Yield10 Bioscience Inc expected to post a loss of 28 cents a share - Earnings Preview
08/03/2024 11:17
* Yield10 Bioscience Inc YTEN.OQ YTEN.O is expected
to show a
fall in quarterly revenue when it reports results on March 12
(estimated) for the period ending December 31 2023
* The Woburn Massachusetts-based company is expected to
report a
61.7% decrease in revenue to $33.33 thousand from $87 thousand a
year ago, according to the mean estimate from 3 analysts, based
on LSEG data.
* LSEG's mean analyst estimate for Yield10 Bioscience Inc
is for
a loss of 28 cents per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Yield10
Bioscience Inc is $2.25, above its last closing price
of $0.26.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Sep. 30 2023 -0.40 -0.39 -0.41 Missed -4.2
Jun. 30 2023 -0.59 -0.54 -0.64 Missed -17.8
Mar. 31 2023 -0.63 -0.63 -0.76 Missed -20
Dec. 31 2022 -0.69 -0.60 -0.67 Missed -10.7
Sep. -0.65 -0.65 -0.71 Missed -9.2
30 2022
Jun. 30 2022 -0.69 -0.69 -0.70 Missed -1.4
Mar. 31 2022 -0.65 -0.65 -0.68 Missed -4.2
Dec. 31 2021 -0.64 -0.63 -0.61 Beat 3.9
This summary was machine generated March 8 at 11:17 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)